United States

People: Chipotle Mexican Grill Inc (CMG.N)

CMG.N on New York Stock Exchange

21 Aug 2017
Change (% chg)

$-2.65 (-0.85%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Flanzraich, Neil 

Mr. Neil W. Flanzraich is an Lead Independent Director of Chipotle Mexican Grill Inc. Mr. Flanzraich is the Executive Chairman of Cantex Pharmaceuticals, Inc. (formerly ParinGenix, Inc.), a privately-owned biotech company, where he previously served as CEO and Chairman, and additionally, he has been a private investor since February 2006. From 1998 through its sale in January 2006 to TEVA Pharmaceuticals Industries, Ltd., he served as Vice Chairman and President of IVAX Corporation, an international pharmaceutical company. From 1995 to 1998, Mr. Flanzraich served as Chairman of the Life Sciences Legal Practice Group of Heller Ehrman LLP, a law firm, and from 1981 to 1994, served as the Senior Vice President and Chief Counsel and member of the Operating and Executive Committees of Syntex Corporation, an international pharmaceutical company. He was a director of Equity One Inc. (NYSE: EQY) until it was acquired on March 1, 2017. Mr. Flanzraich was also previously a director of BELLUS Health Inc. until May 2012, and prior to that served as a director of a number of additional publicly-traded companies. Mr. Flanzraich received an A.B. from Harvard College and a J.D. from Harvard Law School.

Basic Compensation

Total Annual Compensation, USD 160,250
Restricted Stock Awards, USD 120,310
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 280,560

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --